PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

117 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Ott, R. et al.: Epigenome-wide meta-analysis reveals associations between dietary glycemic index and glycemic load and DNA methylation in children and adolescents of different body sizes. Diabetes Care 46, 2067-2075 (2023)
22.
Russell, W.E.* et al.: Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: A randomized, double-masked, controlled trial. Diabetes Care 46, 1005-1013 (2023)
23.
Thorsen, S.U.* et al.: Interaction between dietary iron intake and genetically determined iron overload: Risk of islet autoimmunity and progression to Type 1 diabetes in the TEDDY study. Diabetes Care 46, 1014-1018 (2023)
24.
Uusitalo, U.* et al.: HLA genotype and probiotics modify the association between timing of solid food introduction and islet autoimmunity in the TEDDY Study. Diabetes Care 46, 1839-1847 (2023)
25.
Aslam. A.A.* et al.: Diabetes and obesity in down syndrome across the lifespan: A retrospective cohort study using U.K. electronic health records. Diabetes Care 45, 2892–2899 (2022)
26.
Auzanneau, M.* et al.: Frequency of ketoacidosis at diagnosis of pediatric type 1 diabetes associated with socioeconomic deprivation and Uubanization: Results from the German Multicenter DPV Registry. Diabetes Care 45, 1807-1813 (2022)
27.
Heianza, Y.* et al.: Changes in circulating miR-375-3p and improvements in visceral and hepatic fat contents in response to lifestyle interventions: The CENTRAL trial. Diabetes Care 45, 1911-1913 (2022)
28.
Jacobsen, L.M.* et al.: Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY Study. Diabetes Care 45, 624-633 (2022)
29.
Karl, F. ; Winkler, C. ; Ziegler, A.-G. ; Laxy, M. & Achenbach, P.: Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany. Diabetes Care 45, 837-844 (2022)
30.
Krischer, J.P.* et al.: Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: The TEDDY study. Diabetes Care 45, 2271-2281 (2022)
31.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: A randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care 45, 398-406 (2022)
32.
Küpers, L.K.* et al.: Maternal dietary glycemic index and glycemic load in pregnancy and offspring cord blood DNA methylation. Diabetes Care 45, 1822-1832 (2022)
33.
Ng, K.* et al.: Islet autoantibody type-specific titer thresholds improve stratification of risk of progression to type 1 diabetes in children. Diabetes Care 45, 160-168 (2022)
34.
Rossing, P.* et al.: Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: The FIDELITY analysis. Diabetes Care 45, 2991–2998 (2022)
35.
Schlögl, H. & Stumvoll, M.*: The brains behind SGLT2 inhibition. Diabetes Care 45, 273-275 (2022)
36.
Tobi, E.W.* et al.: Maternal glycemic dysregulation during pregnancy and neonatal blood DNA methylation: Meta-analyses of epigenome-wide association studies. Diabetes Care 45, 614-623 (2022)
37.
Vehik, K.* et al.: Rising hemoglobin A1c in the nondiabetic range predicts progression of type 1 diabetes as well as oral glucose tolerance tests. Diabetes Care 45, 2342-2349 (2022)
38.
Ahuja, V.* et al.: Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: A meta-analysis. Diabetes Care 44, 1062-1069 (2021)
39.
Anand, V.* et al.: Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: Joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S. Diabetes Care 44, 2269-2276 (2021)
40.
Bizzotto, R.* et al.: Processes underlying glycemic deterioration in type 2 diabetes: An IMI DIRECT Study. Diabetes Care 44, 511-518 (2021)